Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning.
Here in Chicago, cherry blossoms are blooming, rat birth control is working , and it finally feels like spring may be upon us. Budget proposals aim to boost U.S.
drugmaking As part of President Trump’s 2027 budget blueprint, the FDA has proposed policies aimed at encouraging domestic development and manufacturing of drugs, such as making it easier for drugmakers to move into clinical testing in the U.S. and giving an “exclusivity” period to U.S.-based generics manufacturers.
Continue to STAT+ to read the full story...
STAT News published a clinical update in Research Highlights on 07 Apr 2026.
The item focuses on STAT+: Novo Nordisk launches high-dose Wegovy.
Review the original article for the full source wording and details.